• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

S2Medical

0.01 SEK

+3.70 %

Less than 1K followers

S2M

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+3.70 %
-20.00 %
-44.55 %
-47.66 %
-47.17 %
-71.28 %
-95.93 %
-99.56 %
-99.84 %

S2Medical operates in the medical technology sector. The company is focused on research and development of various wound healing products. Various products offered include cellulose-based materials and dressings for the healing of burns and chronic wounds. The products are sold under various brands, mainly at a European level. S2Medical was founded in 2013 and is headquartered in Linköping.

Read more
Market cap
5.25M SEK
Turnover
4K SEK
Revenue
14.36M
EBIT %
-18.54 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
21/8
2026

Interim report Q2'26

All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release17 hours ago

Kommuniké från årsstämma i S2Medical AB (publ) den 12 juni 2026

S2Medical
Regulatory press releaseyesterday

S2Medical AB (publ): Fastställd teckningskurs i den föreslagna riktade emissionen till SivlerSkog Group AB

S2Medical
Regulatory press release5/15/2026, 1:29 PM

KALLELSE TILL ÅRSSTÄMMA I S2MEDICAL AB (PUBL)

S2Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/12/2026, 9:17 PM

S2Medical offentliggör förslag om riktad emission av A-aktier och företrädesemission av A- och B-aktier inför årsstämma

S2Medical
Regulatory press release5/5/2026, 11:25 AM

S2Medical AB (publ) publicerar årsredovisningen för 2025

S2Medical
Regulatory press release5/3/2026, 9:28 PM

Rättelse: Senareläggning av årsredovisning för perioden januari – december 2025

S2Medical
Regulatory press release5/2/2026, 9:05 PM

Senareläggande av offentliggörande av årsredovisning

S2Medical
Regulatory press release4/30/2026, 9:20 AM

S2Medical meddelar byte av Certified Adviser till Partner Fondkommission

S2Medical
Regulatory press release4/18/2026, 5:45 PM

S2Medical AB (publ) informerar om byte av revisor inför årsstämman 2026

S2Medical
Regulatory press release2/20/2026, 3:40 PM

Bokslutskommuniké Januari - December 2025 S2Medical AB (publ)

S2Medical
Regulatory press release2/4/2026, 2:10 PM

S2Medical signerar exklusivt distributionsavtal med Life Medical Equipment

S2Medical
Regulatory press release1/30/2026, 5:25 PM

S2Medical validerar europeiskt patent för AMP-teknologi i 18 länder

S2Medical
Press release11/28/2025, 1:02 PM

SivlerSkog Group AB ökar sitt innehav i S2Medical genom strategiskt A-aktieförvärv

S2Medical
Regulatory press release11/21/2025, 4:12 PM

S2Medical AB (publ) genomför riktad emission för att knyta strategisk expert till bolaget

S2Medical
Regulatory press release11/19/2025, 7:54 PM

Finansinspektionen: Flaggningsmeddelande i Avanza Bank Holding AB

S2MedicalAvanza Bank
Regulatory press release9/23/2025, 3:17 PM

S2Medical AB: S2Medical beviljas europeiskt patent för banbrytande antimikrobiell peptidteknologi

S2Medical
Regulatory press release8/22/2025, 7:00 AM

S2Medical AB: DELÅRSRAPPORT JANUARI - JUNI 2025

S2Medical
Regulatory press release6/16/2025, 8:28 AM

Kommuniké från årstämma 2025 i S2Medical AB (publ)

S2Medical
Regulatory press release6/4/2025, 10:24 AM

S2Medical AB: S2Medical expanderar i Mellanöstern - Distributionspartnern bakom Epiprotects framgång tar över försäljningen av bolagets produkter för sårrengöring i Förenade Arabemiraten och Oman

S2Medical
Regulatory press release5/21/2025, 12:23 PM

S2Medical AB: KALLELSE TILL ÅRSSTÄMMA I S2MEDICAL AB (PUBL)

S2Medical